Last updated on May 2010

Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH)


Brief description of study

This study is to evaluate the effect of rosuvastatin 10-20 mg on carotid atherosclerosis progression in Chinese patients by evaluating the change in the percentage of volume of lipid rich necrotic core (LRNC) using high-resolution magnetic resonance imaging (MRI) after 24-months treatment.

Detailed Study Description

The primary objective of this study is to evaluate the effect of rosuvastatin 10-20 mg on carotid atherosclerosis progression in Chinese patients by evaluating the change in the percentage of volume of lipid rich necrotic core (LRNC) using high-resolution magnetic resonance imaging (MRI) after 24-months treatment.

Clinical Study Identifier: NCT00885872

Contact Investigators or Research Sites near you

Start Over

Du Ruixue, Dr.

Chinese PLA General Hospital
Beijing, China
  Connect »